Cholestyramine
NDC 11788-150, Cholestyramine, powder, for suspension, from AiPing Pharmaceutical, Inc..
- Product NDC
- 11788-150
- Status
- Listed
- Labeler
- AiPing Pharmaceutical, Inc.
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214877
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/11788-150 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CHOLESTYRAMINE4 g/9g
Pharmacologic classes
Bile Acid Sequestrant [EPC]; Bile-acid Binding Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 11788-150-17 | 11788015017 | 378 g in 1 JAR (11788-150-17) |
| 11788-150-60 | 11788015060 | 60 POUCH in 1 CARTON (11788-150-60) / 9 g in 1 POUCH (11788-150-16) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/214ea05f-de81-4026-9df9-4ce3820668ee
Use it
Look up 11788-150 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/11788-150 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 11788-150. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.